Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Effect of Alpha Binaural Beat Music on Pain After Orthodontic Separator Placement (ABB-PainRCT)

17 de agosto de 2026 atualizado por: Aga Khan University

The Effect of Alpha Binaural Beat Music on Orthodontic Pain After Placement of Orthodontic Separators: A Randomized Controlled Trial

Orthodontic pain is one of the most frequently reported adverse experiences during fixed appliance therapy and is particularly pronounced during the initial stages of treatment. Placement of orthodontic separators, a routine procedure performed to create interproximal space for orthodontic band placement, often causes discomfort that may negatively influence patient motivation, treatment acceptance, and overall orthodontic experience. Psychological factors, particularly anxiety, may also influence pain perception and contribute to individual differences in pain responses during orthodontic treatment. Therefore, interventions that address both pain and anxiety may improve patient comfort and adaptation to treatment.

Binaural beats are auditory stimuli generated when two slightly different frequencies are presented separately to each ear, resulting in the perception of a third frequency equal to the difference between the two tones. Alpha-frequency binaural beats (8-13 Hz) have been associated with relaxation and reduced psychological arousal and have demonstrated promising analgesic and anxiolytic effects in various medical and dental settings. However, limited evidence exists regarding their role in the management of orthodontic pain following separator placement.

This prospective parallel-arm randomized controlled trial aims to evaluate the effect of alpha-frequency binaural beat stimulation on orthodontic pain and anxiety following separator placement. Seventy-two orthodontically treatment-naïve participants aged 15-30 years with permanent dentition, mild crowding (≤3 mm arch length discrepancy), good periodontal health, and a requirement for fixed orthodontic treatment will be recruited from the orthodontic clinics of Aga Khan University Hospital, Karachi, Pakistan. To minimize potential confounding factors and standardize the painful stimulus, all participants will require bilateral maxillary first molar banding and placement of four elastomeric separators, consisting of one separator mesial and one separator distal to each maxillary first molar. Participants will be randomly allocated in a 1:1 ratio to either an intervention group receiving alpha-frequency binaural beat stimulation or a control group undergoing a standardized five-minute resting period without auditory stimulation.

The binaural beat intervention consists of an 11-Hz alpha-frequency stimulus generated through the presentation of a 285-Hz carrier tone to one ear and a 296-Hz carrier tone to the other ear. Participants assigned to the intervention group will listen to a standardized pre-recorded audio file through stereo headphones for five minutes at designated assessment intervals. Orthodontic pain intensity will be assessed using the Visual Analogue Scale for Pain (VAS-P), anxiety levels will be measured using the Visual Analogue Scale for Anxiety (VAS-A), and analgesic consumption will be recorded during the observation period. Assessments will be conducted before separator placement, during separator placement, and at 6, 24, and 48 hours following the procedure.

The primary objective of this study is to evaluate the effect of alpha-frequency binaural beat stimulation on orthodontic pain intensity 24 hours after separator placement. Secondary objectives include evaluating pain intensity at 6 and 48 hours, anxiety levels, and analgesic consumption during the 48-hour observation period. The findings of this study will provide evidence regarding the effectiveness of alpha-frequency binaural beats as a simple, inexpensive, safe, and non-pharmacological adjunct for reducing orthodontic pain and anxiety and improving patient comfort during the early stages of orthodontic treatment.

Visão geral do estudo

Status

Ainda não está recrutando

Descrição detalhada

This study is a prospective, parallel-arm, randomized controlled clinical trial to be conducted at the Department of Dentistry and Oral Health Sciences, Aga Khan University Hospital, Karachi, Pakistan. The study aims to evaluate the effectiveness of alpha-frequency binaural beat auditory stimulation in reducing orthodontic pain and anxiety associated with orthodontic separator placement.

Orthodontic separators are routinely used during the initial stages of fixed orthodontic treatment to create interproximal space for orthodontic band placement. Although considered a routine orthodontic procedure, separator placement frequently causes discomfort and pain that may negatively affect patient motivation, treatment acceptance, compliance, and overall orthodontic experience. Psychological factors, particularly anxiety, have also been shown to influence pain perception and may contribute to variations in pain responses among orthodontic patients. Consequently, there is growing interest in safe and effective non-pharmacological approaches that may improve patient comfort while avoiding the potential adverse effects associated with analgesic medications.

Binaural beats are an auditory phenomenon produced when two slightly different sound frequencies are presented separately to each ear, resulting in the perception of a third frequency corresponding to the difference between the two tones. Alpha-frequency binaural beats, typically ranging between 8 and 13 Hz, have been associated with relaxation, reduced psychological stress, and decreased anxiety. Previous studies have suggested potential beneficial effects of binaural beats on pain perception and emotional responses; however, evidence regarding their effectiveness following orthodontic separator placement remains limited.

Orthodontically treatment-naïve participants aged 15 to 30 years with permanent dentition, mild crowding (≤3 mm arch length discrepancy), good periodontal health, and a requirement for fixed orthodontic treatment will be screened for eligibility and recruited following informed consent procedures. To minimize potential confounding factors and standardize the painful stimulus across participants, all subjects will require bilateral maxillary first molar banding and placement of four elastomeric separators, consisting of one mesial and one distal separator around each maxillary first molar (two separators per side). Participants will be randomly allocated in a 1:1 ratio to either an intervention group or a control group.

The intervention group will receive alpha-frequency binaural beat stimulation through stereo headphones. The auditory stimulus will be generated by presenting a 285-Hz carrier frequency to one ear and a 296-Hz carrier frequency to the opposite ear, resulting in the perception of an 11-Hz alpha-frequency binaural beat. Participants will listen to a standardized audio track for five minutes at designated assessment intervals. Participants allocated to the control group will undergo an equivalent five-minute quiet resting period without auditory stimulation.

Orthodontic pain intensity will be assessed using the Visual Analogue Scale for Pain (VAS-P), while anxiety levels will be assessed using the Visual Analogue Scale for Anxiety (VAS-A). Outcome assessments will be performed before separator placement, during separator placement, and at 6, 24, and 48 hours following the procedure. Analgesic consumption during the observation period will also be recorded.

The primary objective of the study is to evaluate the effect of alpha-frequency binaural beat music on orthodontic pain intensity 24 hours after separator placement. Secondary objectives include evaluating orthodontic pain intensity at 6 and 48 hours, anxiety levels, and analgesic consumption during the observation period. The findings of this study may provide evidence regarding a simple, inexpensive, safe, and non-pharmacological adjunct that could improve patient comfort, reduce procedure-related anxiety, and enhance the overall orthodontic treatment experience during the initial stages of orthodontic care.

Tipo de estudo

Intervencional

Inscrição (Estimado)

72

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Contato de estudo

Estude backup de contato

  • Nome: Syed Muhammad Ali Gilani, Bachelor of Dental Surgery
  • Número de telefone: +923317500883
  • E-mail: ali.gilani@aku.edu

Locais de estudo

    • Sindh
      • Karachi, Sindh, Paquistão, 74800
        • Aga Khan University Hospital
        • Contato:
          • Syed Muhammad Ali Gilani, Bachelor of Dental Surgery
          • Número de telefone: +923317500883
          • E-mail: ali.gilani@aku.edu
        • Contato:
        • Subinvestigador:
          • Muhammad Raif Ilyas, Bachelor of Dental Surgery
        • Investigador principal:
          • Mubassar FIDA, BDS, MCPS & FCPS Orthodontics
        • Subinvestigador:
          • Rashna Hoshang Sukhia, BDS, MSc, FCPS, MOrth RCSEd

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

  • Filho
  • Adulto

Aceita Voluntários Saudáveis

Não

Descrição

Inclusion Criteria:

  • Patients aged 15-30 years.
  • Permanent dentition.
  • Mild crowding (≤3 mm arch length discrepancy).
  • Good periodontal health.
  • Requirement for fixed orthodontic treatment.
  • Requirement for bilateral maxillary first molar banding.
  • Requirement for placement of four elastomeric separators, consisting of one separator mesial and one separator distal to each maxillary first molar.
  • Ability to understand study instructions and complete study assessments.
  • Willingness to use stereo headphones.
  • Provision of written informed consent.

Exclusion Criteria:

  • Previous fixed orthodontic treatment.
  • Congenital or acquired hearing impairment.
  • Use of hearing aids or assistive listening devices.
  • History of tinnitus, hyperacusis, or sound sensitivity.
  • Active ear infection.
  • Recent upper respiratory tract infection associated with ear symptoms.
  • Neurological disorders.
  • Psychiatric disorders requiring treatment, including anxiety and depressive disorders.
  • Current use of analgesics, anti-inflammatory medications, antidepressants, anxiolytics, antipsychotics, or sedatives.
  • Chronic pain disorders.
  • Active periodontal disease or significant gingival inflammation.
  • Active dental pain, pulpal pathology, or oral infection.
  • Inability or unwillingness to use stereo headphones.
  • Inability to understand study instructions or complete study assessments.

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Cuidados de suporte
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Nenhum (rótulo aberto)

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Alpha Binaural Beat Music
Participants aged 15-30 years with permanent dentition, mild crowding (≤3 mm arch length discrepancy), good periodontal health, and no history of previous fixed orthodontic treatment will undergo standardized bilateral maxillary first molar separator placement using four elastomeric separators, with one separator placed mesial and one separator placed distal to each maxillary first molar. Participants assigned to this arm will receive alpha-frequency binaural beat auditory stimulation through stereo headphones for five minutes at designated assessment intervals. Orthodontic pain intensity, anxiety levels, and analgesic consumption will be evaluated during the 48-hour observation period following separator placement.
Participants assigned to the intervention group will receive alpha-frequency binaural beat auditory stimulation through stereo headphones following orthodontic separator placement. The auditory stimulus will be generated by presenting a 285-Hz carrier frequency to one ear and a 296-Hz carrier frequency to the opposite ear, resulting in the perception of an 11-Hz binaural beat within the alpha frequency range. Participants will listen to the standardized audio stimulus for five minutes at designated assessment intervals during the 48-hour observation period following separator placement.
Outros nomes:
  • 11-Hz Alpha Binaural Beat Audio Stimulation
  • Alpha Binaural Beat Music
Sem intervenção: Control
Participants aged 15-30 years with permanent dentition, mild crowding (≤3 mm arch length discrepancy), good periodontal health, and no history of previous fixed orthodontic treatment will undergo standardized bilateral maxillary first molar separator placement using four elastomeric separators, with one separator placed mesial and one separator placed distal to each maxillary first molar. Participants allocated to this arm will undergo a standardized five-minute quiet resting period without auditory stimulation. Orthodontic pain intensity, anxiety levels, and analgesic consumption will be evaluated during the 48-hour observation period following separator placement.

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Orthodontic Pain Intensity
Prazo: 24 hours after orthodontic separator placement
Orthodontic pain intensity measured using the Visual Analogue Scale for Pain (VAS-P). Scores range from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.
24 hours after orthodontic separator placement

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Orthodontic Pain Intensity at 6 Hours
Prazo: 6 hours after orthodontic separator placement
Orthodontic pain intensity measured using the Visual Analogue Scale for Pain (VAS-P). Scores range from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.
6 hours after orthodontic separator placement
Orthodontic Pain Intensity at 48 Hours
Prazo: 48 hours after orthodontic separator placement
Orthodontic pain intensity measured using the Visual Analogue Scale for Pain (VAS-P). Scores range from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.
48 hours after orthodontic separator placement
Orthodontic Pain Intensity During Separator Placement
Prazo: Periprocedural (during orthodontic separator placement)
Orthodontic pain intensity measured using the Visual Analogue Scale for Pain (VAS-P). Scores range from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain intensity.
Periprocedural (during orthodontic separator placement)
Anxiety Level
Prazo: Baseline, periprocedural, 6 hours, 24 hours, and 48 hours after orthodontic separator placement
Anxiety measured using the Visual Analogue Scale for Anxiety (VAS-A). Scores range from 0 (no anxiety) to 10 (worst imaginable anxiety). Higher scores indicate greater anxiety.
Baseline, periprocedural, 6 hours, 24 hours, and 48 hours after orthodontic separator placement
Analgesic Consumption
Prazo: Through 48 hours after orthodontic separator placement
Number of analgesic tablets consumed during the observation period following orthodontic separator placement.
Through 48 hours after orthodontic separator placement

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Patrocinador

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Estimado)

3 de agosto de 2026

Conclusão Primária (Estimado)

16 de setembro de 2026

Conclusão do estudo (Estimado)

18 de setembro de 2026

Datas de inscrição no estudo

Enviado pela primeira vez

4 de agosto de 2026

Enviado pela primeira vez que atendeu aos critérios de CQ

17 de agosto de 2026

Primeira postagem (Real)

19 de agosto de 2026

Atualizações de registro de estudo

Última Atualização Postada (Real)

19 de agosto de 2026

Última atualização enviada que atendeu aos critérios de controle de qualidade

17 de agosto de 2026

Última verificação

1 de agosto de 2026

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

NÃO

Descrição do plano IPD

Individual participant data will not be made publicly available. The study is a single-center investigator-initiated trial, and sharing of individual participant data is restricted to protect participant confidentiality and comply with institutional policies and ethics requirements.

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever